448 related articles for article (PubMed ID: 21865693)
61. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
62. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
Suzuki S; Kobayashi H; Sato H; Arakawa M
Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
[TBL] [Abstract][Full Text] [Related]
63. Reconstitution of immunological imbalance in SCID mice given tonsillar mononuclear cells from patients with IgA nephropathy.
Kusakari C; Takasaka T
Acta Otolaryngol Suppl; 1993; 508():19-22. PubMed ID: 8285038
[TBL] [Abstract][Full Text] [Related]
64. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
65. Oxidative stress in IgA nephropathy.
Coppo R; Camilla R; Amore A; Peruzzi L
Nephron Clin Pract; 2010; 116(3):c196-8, discussion c199. PubMed ID: 20606479
[TBL] [Abstract][Full Text] [Related]
66. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.
Giannakakis K; Feriozzi S; Perez M; Faraggiana T; Muda AO
J Am Soc Nephrol; 2007 Dec; 18(12):3139-46. PubMed ID: 17978312
[No Abstract] [Full Text] [Related]
67. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
[TBL] [Abstract][Full Text] [Related]
68. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
69. The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy.
Xie LS; Qin W; Fan JM; Huang J; Xie XS; Li Z
Clin Invest Med; 2010 Feb; 33(1):E5-13. PubMed ID: 20144270
[TBL] [Abstract][Full Text] [Related]
70. Tonsillar CD4+CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats.
Huang H; Peng Y; Long XD; Liu Z; Wen X; Jia M; Liang Y; Huang A
Am J Nephrol; 2013; 37(5):472-80. PubMed ID: 23635548
[TBL] [Abstract][Full Text] [Related]
71. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
Novak J; Julian BA; Tomana M; Mestecky J
Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
[TBL] [Abstract][Full Text] [Related]
72. Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients.
Shao J; Peng Y; He L; Liu H; Chen X; Peng X
Hum Immunol; 2014 Oct; 75(10):1034-9. PubMed ID: 25167771
[TBL] [Abstract][Full Text] [Related]
73. Aberrant glycosylation of IgA from patients with IgA nephropathy.
Baharaki D; Dueymes M; Perrichot R; Basset C; Le Corre R; Clèdes J; Youinou P
Glycoconj J; 1996 Aug; 13(4):505-11. PubMed ID: 8872105
[TBL] [Abstract][Full Text] [Related]
74. Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF.
He L; Peng X; Chen Y; Liu G; Liu Z; Zhu J; Liu Y; Liu H; Liang Y; Liu F; Sun L; Peng Y
Am J Nephrol; 2016; 43(3):179-94. PubMed ID: 27073891
[TBL] [Abstract][Full Text] [Related]
75. Aberrant glycosylation in IgA nephropathy (IgAN).
Coppo R; Amore A
Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
[TBL] [Abstract][Full Text] [Related]
76. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.
Gharavi AG; Moldoveanu Z; Wyatt RJ; Barker CV; Woodford SY; Lifton RP; Mestecky J; Novak J; Julian BA
J Am Soc Nephrol; 2008 May; 19(5):1008-14. PubMed ID: 18272841
[TBL] [Abstract][Full Text] [Related]
77. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
Renfrow MB; Cooper HJ; Tomana M; Kulhavy R; Hiki Y; Toma K; Emmett MR; Mestecky J; Marshall AG; Novak J
J Biol Chem; 2005 May; 280(19):19136-45. PubMed ID: 15728186
[TBL] [Abstract][Full Text] [Related]
78. Histological Correlation between Tonsillar and Glomerular Lesions in Patients with IgA Nephropathy Justifying Tonsillectomy: A Retrospective Cohort Study.
Joh K; Ueda H; Katayama K; Kitamura H; Watanabe K; Hotta O
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791337
[TBL] [Abstract][Full Text] [Related]
79. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation].
Matousovic K; Konecný K; Mĕstecký J; Tomana M; Novák J
Cas Lek Cesk; 2002 Nov; 141(23):729-34. PubMed ID: 12650029
[TBL] [Abstract][Full Text] [Related]
80. Clinical and Pathological Implications of Increases in Tonsillar CD19
Cai Y; Chen MX; Deng YJ; Liu LL; Lin XP; Lu PF; Guo YY; Han M
Curr Med Sci; 2022 Feb; 42(1):93-99. PubMed ID: 35167001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
